Personalized Prescription of Chemotherapy Based on Assessment of mRNA Expression of BRCA1, RRM1, ERCC1, TOP1, TOP2α, TUBβ3, TYMS, and GSTP1 Genes in Tumors Compared to Standard Chemotherapy in the Treatment of Non-Small-Cell Lung Cancer

Objectives: A growing body of evidence suggests the important role of chemosensitive gene expression in the prognosis of patients with lung cancer. However, studies on combined gene expression assessments for personalized prescriptions of chemotherapy regimens in patients have not yet been conducted...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsyganov, Matvey M., Rodionov, Evgeny O., Ibragimova, Marina K., Miller, Sergey V., Cheremisina, Olga V., Frolova, Irina G., Tuzikov, Sergey A., Litviakov, Nikolai V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605448/
https://www.ncbi.nlm.nih.gov/pubmed/36294786
http://dx.doi.org/10.3390/jpm12101647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605448/
https://www.ncbi.nlm.nih.gov/pubmed/36294786
http://dx.doi.org/10.3390/jpm12101647

Ejemplares similares